The present disclosure provides biomarkers useful as companion diagnostics for detecting glycocalyx-based disease that is amenable to treatment using compounds designed for improving the condition of the glycocalyx and/or reducing inflammation and/or oxidative damage, as well as related compositions, kits, and methods.
本公开提供了作为伴随诊断的
生物标志物,用于检测适用于使用旨在改善
糖类壁和/或减少炎症和/或氧化损伤状况的化合物治疗的基于
糖类壁的疾病,以及相关的组合物、试剂盒和方法。